KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardinal Health (CAH) Change in Cash (2016 - 2025)

Historic Change in Cash for Cardinal Health (CAH) over the last 17 years, with Q4 2025 value amounting to -$1.8 billion.

  • Cardinal Health's Change in Cash fell 29257.69% to -$1.8 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$1.0 billion, marking a year-over-year decrease of 3125.79%. This contributed to the annual value of -$1.3 billion for FY2025, which is 21911.07% down from last year.
  • As of Q4 2025, Cardinal Health's Change in Cash stood at -$1.8 billion, which was down 29257.69% from $719.0 million recorded in Q3 2025.
  • Over the past 5 years, Cardinal Health's Change in Cash peaked at $2.4 billion during Q2 2022, and registered a low of -$2.3 billion during Q3 2024.
  • Moreover, its 5-year median value for Change in Cash was -$17.0 million (2021), whereas its average is -$46.8 million.
  • In the last 5 years, Cardinal Health's Change in Cash plummeted by 367600.0% in 2021 and then surged by 272391.3% in 2022.
  • Over the past 5 years, Cardinal Health's Change in Cash (Quarter) stood at $698.0 million in 2021, then crashed by 76.79% to $162.0 million in 2022, then surged by 348.77% to $727.0 million in 2023, then rose by 29.71% to $943.0 million in 2024, then crashed by 292.58% to -$1.8 billion in 2025.
  • Its Change in Cash stands at -$1.8 billion for Q4 2025, versus $719.0 million for Q3 2025 and $548.0 million for Q2 2025.